Integrated DNA technologies INC:1107504 [22-009290] purchase of the antisense oligonucleotide (ASO) for the blocking of the replication of human immunodeficiency virus (HIV).
Ended Awarded
- Contract number
- 75N95A22F00001
- Awardee
-
Integrated DNA Technologies, Inc. UEI P55FTN1UMYZ1 Part of Danaher Corporation
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,406
Award facts
- Contract value 100% obligated
- $13,406.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Coralville, IA 52241, USA
Award details come from SAM.gov/FPDS.
About this award
Integrated DNA Technologies, Inc. (IDT), a leading manufacturer of specialized nucleic acid products based in Coralville, Iowa, received a $13,406.24 firm fixed-price contract award from the National Institute of Neurological Disorders and Stroke on June 5, 2022, for the purchase of antisense oligonucleotides (ASOs) designed to block the replication of human immunodeficiency virus (HIV). This contract was awarded as a call against an existing Blanket Purchase Agreement and included no set-aside designation, demonstrating IDT's competitive standing in open market procurement. The work is scheduled for completion by June 13, 2022.
IDT, a subsidiary of Danaher Corporation, is a parent corporate entity registered as a federal contractor since 2001 that specializes in custom DNA and RNA oligonucleotides, sequencing products, and molecular biology supplies. The company maintains a $10 million Blanket Purchase Agreement with the National Institute of Neurological Disorders and Stroke that enables rapid procurement of custom oligonucleotides and related reagents to support critical biomedical research initiatives. IDT's federal contract portfolio demonstrates consistent delivery of advanced scientific products across multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense, supporting research in areas ranging from neurodegenerative disorders to viral research and pandemic response.
Quick answers
Who was awarded contract 75N95A22F00001?
75N95A22F00001 was awarded to Integrated DNA Technologies, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on June 5, 2022.
How much is contract 75N95A22F00001 worth?
The government has obligated $13,406 on 75N95A22F00001.
Is contract 75N95A22F00001 an order under another contract?
Yes. 75N95A22F00001 is a BPA call under HHSN263201500214B, a blanket purchase agreement.
Was contract 75N95A22F00001 competed?
The extent of competition for 75N95A22F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award